Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity

Código QR

Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity

The treatment for nonmetastatic castration-resistant prostate cancer (nmCRPC) is a highly unmet medical need. The classic treatment approach for these patients—androgen deprivation therapy (ADT) alone—until metastatic progression is now considered suboptimal. Several randomized phase III clinical tr...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fernando López-Campos, Antonio Conde-Moreno, Marta Barrado Los Arcos, Antonio Gómez-Caamaño, Raquel García-Gómez, Asunción Hervás Morón
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	nonmetastatic castration-resistant prostate cancer second generation anti-androgens apalutamide enzalutamide darolutamide overall survival Medicine R
Acceso en línea:	https://doaj.org/article/ebbad03a6fdf4b23a5af69a2cb8f690b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Avances en el tratamiento de cáncer de próstata resistente a la castración: énfasis en nuevas terapias hormonales
por: Berlin,Alejandro, et al.
Publicado: (2015)

Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
por: Caffo O, et al.
Publicado: (2016)

Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance
por: Shangwei Zhong, et al.
Publicado: (2021)

Treatment patterns and survival in metastatic castration‐sensitive prostate cancer in the US Veterans Health Administration
por: Stephen J. Freedland, et al.
Publicado: (2021)

Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
por: Nikolai A. Ognerubov
Publicado: (2021)

An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
por: Josephina P. M. Vrouwe, et al.
Publicado: (2021)

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
por: Archibald M, et al.
Publicado: (2016)

A phase II pilot trial investigating the efficacy and activity of single agent granulocyte macrophage colony-stimulating factor as maintenance approach in castration - resistant prostate cancer patients responding to chemotherapy
por: Chadi Nabhan, et al.
Publicado: (2011)

Advanced Therapeutic Options for Treatment of Metastatic Castration Resistant Prostatic Adenocarcinoma
por: Faiza Naseer, et al.
Publicado: (2021)

Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
por: Aasems Jacob, et al.
Publicado: (2021)

TRACING THE CRIMINAL POLICY ON CASTRATION AND COMMUNITY RESPONSE
por: Mompang L Panggabean
Publicado: (2021)

Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
por: Tai Z, et al.
Publicado: (2020)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Huan Xu, et al.
Publicado: (2021)

Effect of Concurrent Training and Supplementation with β-Hydroxy- β-Methylbutyirate (HMB) on the Prostate: Alterations in the Androgen Receptor and Inflammation
por: Baptista,Danilo Bianchini, et al.
Publicado: (2018)

A Mansonone Derivative Coupled with Monoclonal Antibody 4D5-Modified Chitosan Inhibit AKR1C3 to Treat Castration-Resistant Prostate Cancer
por: Zhou M, et al.
Publicado: (2020)

Folic Acid–Modified miR-491-5p–Loaded ZIF-8 Nanoparticles Inhibit Castration-Resistant Prostate Cancer by Regulating the Expression of EPHX1
por: Guanqun Ju, et al.
Publicado: (2021)

Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1
por: Zhang Y, et al.
Publicado: (2021)

Stevens-Johnson Syndrome Caused by Enzalutamide: A Case Report and Literature Review
por: Min Deng, et al.
Publicado: (2021)

Critical appraisal of cabazitaxel in the management of advanced prostate cancer
por: Sumanta Kumar Pal, et al.
Publicado: (2010)

MODERN APPROACH TO MOLECULAR CHARACTERIZATION OF PROSTATE TUMORS
por: E. P. Khvostova, et al.
Publicado: (2012)

Laparoscopic Castration Using Bipolar Forceps vs. Orchiectomy in Dogs: A Comparison of Two Techniques
por: Inês Tenreiro Tavares, et al.
Publicado: (2021)

3-<i>O</i>-Carbamoyl-5,7,20-<i>O</i>-trimethylsilybins: Synthesis and Preliminary Antiproliferative Evaluation
por: Sitong Wu, et al.
Publicado: (2021)

<i>AC016745.3</i> Regulates the Transcription of AR Target Genes by Antagonizing NONO
por: Yali Lu, et al.
Publicado: (2021)

Updates on Molecular and Biochemical Development and Progression of Prostate Cancer
por: Omar Fahmy, et al.
Publicado: (2021)

Six-month leuprorelin acetate depot formulations in advanced prostate cancer: a clinical evaluation
por: Tunn UW, et al.
Publicado: (2013)

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy
por: Karen A. Autio, et al.
Publicado: (2021)

Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer
por: Mohammad Taheri, et al.
Publicado: (2021)

Dinámica temporal en la relación entre el isópodo parásito Aporobopyrus curtatus (Crustacea: Isopoda: Bopyridae) y el cangrejo anomuro Petrolisthes armatus (Crustacea: Decapoda: Porcellanidae) en el sur de Brasil
por: Miranda,Ivana, et al.
Publicado: (2010)

Overcoming prostate cancer drug resistance with a novel organosilicon small molecule
por: Rui Zhao, et al.
Publicado: (2021)

A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth
por: Joanna L Gillis, et al.
Publicado: (2021)

Synthesis of magnetic molecularly imprinted polymers with excellent biocompatibility for the selective separation and inhibition of testosterone in prostate cancer cells
por: Tang X, et al.
Publicado: (2017)

Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real‐world evidence study
por: Jui‐Ming Liu, et al.
Publicado: (2021)

Comparación de distintos métodos para evaluar la función androgénica en el adulto mayor
por: Campusano M,Claudia, et al.
Publicado: (2006)

NK Cells Can Preferentially Target Prostate Cancer Stem-like Cells via the TRAIL/DR5 Signaling Pathway
por: Taiga Seki, et al.
Publicado: (2021)

Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
por: Shengnan Bao, et al.
Publicado: (2021)

Effect of castration and vitamin E supplementation on carcass and meat quality of Santa Inês lambs
por: André Torres-Geraldo, et al.
Publicado: (2019)

Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients
por: Benedikt Hoeh, et al.
Publicado: (2021)

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second‐line antiandrogen therapy era
por: Isaac E. Kim, et al.
Publicado: (2021)

Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?
por: Nicolas Giraud, et al.
Publicado: (2021)

Management of Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Recommendations of a Multidisciplinary Panel of Experts from South America
por: Ray Manneh, et al.
Publicado: (2021)